Translucence Biosystems, Inc.
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.4Mattributed |
|---|---|
| Latest round | grant, $1.4M, 2025-01-01attributed |
| Founded | 2018 |
| Headquarters | irvine, ca, usa |
| Industry | unknown |
| Stage | unknown |
| Website | translucencebio.com |
Translucence Biosystems develops 3D whole-brain imaging and analysis tools that combine tissue clearing, light-sheet microscopy, and AI quantification. It serves CNS-drug developers and academic neuroscience labs scoring drug effects at single-cell resolution across whole organs. Its end-to-end pipeline from sample prep to cellular quantification is the kind of stack a typical CRO has to outsource piecewise.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $1.4M | undisclosed |
Detected tech stack
Cloudflare, reCAPTCHA, Google Analytics, Google Font API, Google Hosted Libraries, Google Tag Manager, Stripe, jQuery CDN, jquery 3.5.1, moment 0, @stripe/stripe-js
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.4M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.4M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | translucencebio.com, read 2026-05-08 |
| Description | self-reported | translucencebio.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.